Whitefish, MT / September 23, 2014 / OxySure Systems Inc. (OTCQB: OXYS), developer of life-saving and easy-to-use emergency oxygen solutions leveraging its oxygen from powder technology, recently announced that it was selected by the United States Patent and Trademark Office ("USPTO") to exhibit its OxySure Model 615 portable emergency oxygen system and other technologies at the USPTO's Innovation Expo at The Smithsonian.
"We are honored and thrilled to be selected by the USPTO to participate in this historic event," said OxySure Systems Inc. CEO Julian Ross in a recent press release discussing the USPTO's invitation to the innovation event. "We remain committed to innovation to save and improve lives, advance our common goals for our communities and society, and to maintain our global leadership."
The Innovation Expo, set to take place on November 1st and 2nd, is a collaboration between the USPTO and The Smithsonian designed to exhibit, showcase and celebrate American innovation and ingenuity. Candidates were selected from thousands of patent holders that invented and commercialized breakthrough technologies and have attained commercial success and influence.
OxySure's Model 615 is a portable emergency oxygen system using OxySure's "oxygen from powder" technology that is both safe and efficacious. Similar to the AEDs produced by companies like Johnson and Johnson (NYSE: JNJ) and St. Jude Medical Inc. (NYSE: STJ), the device is designed to save lives during emergency situations where medical oxygen can help, such as heart attacks, strokes, asthma attacks and more.
Since its introduction, the OxySure Model 615 has been instrumental in saving thousands of lives throughout the U.S. and around the world. OxySure has installed their devices in a number of end markets, ranging from schools to workplaces, where it's often housed next to AEDs. Recently, the company also introduced a double-cabinet AED and OxySure solution that has picked up steam.
Shares of OxySure Systems Inc. rose more than 2% in mid-day trading on Monday, September 22, 2014 following the news release.
About OxySure Systems Inc.
OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments.
For more information, please see the following resources:
- Company Website
- Company Fact Sheet
- Taglich Brothers Buy Rating Target $2.10
- Matt Lauer Talks OxySure
- OxySure Saves Baseball Player
Disclosure:
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://secfilings.com/Disclaimer.aspx
SOURCE: Emerging Growth LLC